William Allan Corp’s West Pharmaceutical WST Stock Holding History

William Allan Corp’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.79M	Sell	13,349 -177	-1%	-$54.1K	2.34%	15
2026 Q1	$3.39M	Buy	13,526 +363	+3%	+$90.3K	2.01%	21
2025 Q4	$3.62M	Sell	13,163 -659	-5%	-$180K	2.05%	20
2025 Q3	$3.63M	Sell	13,822 -457	-3%	-$111K	2.03%	22
2025 Q2	$3.12M	Buy	14,279 +3,556	+33%	+$760K	1.82%	24
2025 Q1	$2.4M	Buy	10,723 +3,340	+45%	+$921K	1.51%	28
2024 Q4	$2.42M	Buy	7,383 +383	+5%	+$121K	1.49%	28
2024 Q3	$1.11M	Buy	7,000 +3,705	+112%	+$1.13M	0.69%	38
2024 Q2	$1.08M	Buy	+3,295	New	+$1.16M	0.73%	36

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

William Allan Corp's WST Position: Q2 2026 in Review

William Allan Corp reduced its West Pharmaceutical (WST) stake by 1.3% in Q2 2026, selling an estimated $54.1K and leaving 13,349 shares worth $4.79M. The position accounts for 2.34% of the portfolio, ranked #15.

William Allan Corp first reported a position in WST in Q2 2024 and has held it in 9 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

William Allan Corp held 13,349 shares of West Pharmaceutical worth $4.79M as of Q2 2026.
William Allan Corp sold 177 West Pharmaceutical shares in Q2 2026, an estimated $54.1K.
West Pharmaceutical made up 2.34% of William Allan Corp's portfolio in Q2 2026, its #15 holding.
William Allan Corp first reported a position in West Pharmaceutical in Q2 2024 and has held it in 9 quarters since.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on William Allan Corp's 13F filing for Q2 2026, filed 28 Jul 2026.